An inspirational swimming coach from West Lothian diagnosed with stage 4 cancer after turning yellow while holidaying in ...

The following is a summary of “A novel predictive method for URS and laser lithotripsy using machine learning and explainable ...

GSK & Spero Therapeutics announce PIVOT-PO phase III study for tebipenem HBr stopped early for efficacy following review by IDMC: London, UK Friday, May 30, 2025, 15:00 Hrs [IST] ...

Surgeons from Keck Medicine of USC and UCLA Health have performed the world's first-in-human bladder transplant.

The patency rate at 6 months was higher for the silicone-coated metallic stent vs double-J stent. A silicone-covered metallic stent maintains patency better than a double-J stent in patients with ...

A California cancer survivor was the recipient of the world's first in-human bladder transplant this month thanks to a pair ...

A California cancer survivor was the recipient of the world's first in-human bladder transplant this month thanks to a pair ...

UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the presentation of the uTRACT Registry ...

WHEN Alan Orchard nearly collapsed on a bike ride through the Lancashire hills in 2023, no one imagined he’d be dead just ...

AstraZeneca has revealed the data for Imfinzi in muscle-invasive bladder cancer (MIBC) that it hopes will be enough to secure FDA approval – although the jury is out on that. The clinical ...

After rejecting ImmunityBio’s Anktiva last year, the FDA has cleared the drug as a treatment for bladder cancer, making it the company’s first commercial-stage product. Anktiva (nogapendekin ...

We know from the phase 2 TROPHY-U-01 trial that sacituzumab govitecan is an active drug, with an objective response rate of ...